Healthcare Services

Renal Insufficiency Industry Expansion Forecast Showing Market Size of $20.5 Billion by 2030 at 11.1% CAGR

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Renal Insufficiency Market From 2026 To 2030?

The renal insufficiency market has seen substantial growth in recent years. Its value is expected to rise from $12.1 billion in 2025 to $13.48 billion in 2026, indicating a compound annual growth rate (CAGR) of 11.4%. The historical expansion of this market stems from factors such as the increasing occurrence of diabetes and hypertension, the broadening of dialysis center networks, a greater adoption of ACE inhibitors and ARBs, the rising identification of chronic kidney disease, and better access to renal care provisions.

The market for renal insufficiency is anticipated to undergo significant expansion over the forthcoming years. By 2030, its value is projected to reach $20.51 billion, expanding at a compound annual growth rate (CAGR) of 11.1%. This projected growth is driven by factors such as the increasing acceptance of home dialysis options, heightened investments in regenerative medical treatments, the broadening scope of digital patient oversight, a rising need for individualized renal care strategies, and a stronger emphasis on decelerating the disease’s advancement. Notable trends foreseen for this period encompass a greater integration of advanced dialysis methods, an intensified focus on managing the disease in its initial stages, an expanding application of multi-drug therapies, the proliferation of at-home treatment alternatives, and a reinforced commitment to patient-centered care approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

What Key Drivers Are Influencing The Growth Of The Renal Insufficiency Market?

The rising incidence of high blood pressure and diabetes cases is projected to stimulate the expansion of the renal insufficiency market moving forward. These conditions are linked to various factors such as unhealthy dietary habits, insufficient physical activity, obesity, genetic predisposition, and an aging demographic. High blood pressure contributes to kidney damage by scarring blood vessels and reducing their filtration capacity, while diabetes leads to the thickening and overworking of kidney vessels due to elevated blood sugar. Both conditions accelerate kidney deterioration, ultimately resulting in renal insufficiency. For example, according to the National Health Service, a UK-based government agency, it was reported in May 2024 that the number of high blood pressure diagnoses in the South East increased by 71,120 patients in December 2023, showing a 5.4% rise compared to December 2022. Additionally, in April 2023, the British Diabetic Association, a UK-based charity organization, stated that 4.3 million people in the UK are living with a diabetes diagnosis. Thus, the increasing occurrence of high blood pressure and diabetes cases is driving the growth of the renal insufficiency market.

Which Segments Are Included In The Analysis Of The Renal Insufficiency Market?

The renal insufficiency market covered in this report is segmented –

1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types

2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes

Subsegments:

1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate

2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)

3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy

4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy

Which Upcoming Trends Are Expected To Influence The Renal Insufficiency Market?

Leading companies in the renal insufficiency market are actively developing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with the aim of addressing renal and cardiovascular complications in patients diagnosed with diabetes and chronic kidney disease (CKD). These GLP-1 RAs work by improving glucose control, reducing inflammation, and lowering oxidative stress within the kidneys, thereby hindering the advancement of renal insufficiency. For instance, in January 2025, Novo Nordisk, a pharmaceutical firm based in Denmark, secured Food and Drug Administration (FDA) approval for its medication, Ozempic (semaglutide). This approval specifically allows for its use to decrease the risk of kidney disease worsening, kidney failure, and cardiovascular death in adults suffering from type 2 diabetes and chronic kidney disease (CKD). This regulatory milestone emphasizes the growing importance of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a comprehensive strategy for managing both diabetes and renal insufficiency, thereby meeting significant unmet needs in patients with progressive CKD.

Which Key Industry Participants Are Active In The Renal Insufficiency Market?

Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation

Read the full renal insufficiency market report here:

https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Renal Insufficiency Market?

North America was the largest region in the renal insufficiency market in 2025. The regions covered in the renal insufficiency market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Renal Insufficiency Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp

Browse Through More Reports Similar to the Global Renal Insufficiency Market 2026, By The Business Research Company

Rare Kidney Diseases Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Chronic Kidney Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Veterinary Renal Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795